TP53 and Familial prostate cancer: Furthermore, with regards to TCA cycle regulation, Tsui et al. [36] illustrated that the induction of p53 levels in prostate cancer cells through camptothecin treatment or by an expression vector markedly reduced mitochondrial aconitase expression.